Amgen (AMGN), AstraZeneca (AZN) to Present Brodalumab Phase 3 Results at Psoriasis: From Gene to Clinic Congress
Tweet Send to a Friend
Amgen (NASDAQ: AMGN) and AstraZeneca (NYSE: AZN) announced that additional results from AMAGINE-1, a pivotal, multi-arm Phase 3 trial evaluating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
